Read + Share
Amedeo Smart
Independent Medical Education
Ait Benichou S, Jauvin D, De Serres-Berard T, Pierre M, et al. Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1. Gene Ther 2022;29:698-709.PMID: 35075265
Email
LinkedIn
Facebook
Twitter
Privacy Policy